Phosphorylation Status of 72 KDa MMP-2 Determines Its Structure and Activity in Response to Peroxynitrite
Overview
Authors
Affiliations
Matrix metalloproteinase-2 (MMP-2) is a key intra- and extra-cellular protease which contributes to several oxidative stress related pathologies. A molecular understanding of 72 kDa MMP-2 activity, directly mediated by S-glutathiolation of its cysteine residues in the presence of peroxynitrite (ONOO(-)) and by phosphorylation of its serine and threonine residues, is essential to develop new generation inhibitors of intracellular MMP-2. Within its propeptide and collagen binding domains there is an interesting juxtaposition of predicted phosphorylation sites with nearby cysteine residues which form disulfide bonds. However, the combined effect of these two post-translational modifications on MMP-2 activity has not been studied. The activity of human recombinant 72 kDa MMP-2 (hrMMP-2) following in vitro treatments was measured by troponin I proteolysis assay and a kinetic activity assay using a fluorogenic peptide substrate. ONOO(-) treatment in the presence of 30 µM glutathione resulted in concentration-dependent changes in MMP-2 activity, with 0.1-1 µM increasing up to twofold and 100 µM attenuating its activity. Dephosphorylation of MMP-2 with alkaline phosphatase markedly increased its activity by sevenfold, either with or without ONOO(-). Dephosphorylation of MMP-2 also affected the conformational structure of the enzyme as revealed by circular dichroism studies, suggesting an increase in the proportion of α-helices and a decrease in β-strands compared to the phosphorylated form of MMP-2. These results suggest that ONOO(-) activation (at low µM) and inactivation (at high µM) of 72 kDa MMP-2, in the presence or absence of glutathione, is also influenced by its phosphorylation status. These insights into the role of post-translational modifications in the structure and activity of 72 kDa MMP-2 will aid in the development of inhibitors specifically targeting intracellular MMP-2.
Bains A, Naba A Expert Rev Proteomics. 2024; 21(11):463-481.
PMID: 39512072 PMC: 11602344. DOI: 10.1080/14789450.2024.2427136.
In Vivo Study on Doxycycline Protective Mechanisms during Myocardial Ischemia Injury in Rats.
Krzywonos-Zawadzka A, Olejnik A, Sawicki G, Bil-Lula I Biomedicines. 2024; 12(3).
PMID: 38540247 PMC: 10967757. DOI: 10.3390/biomedicines12030634.
Immunomodulatory roles of metalloproteinases in rheumatoid arthritis.
Bian Y, Xiang Z, Wang Y, Ren Q, Chen G, Xiang B Front Pharmacol. 2023; 14:1285455.
PMID: 38035026 PMC: 10684723. DOI: 10.3389/fphar.2023.1285455.
Naureen U, Khosa A, Mukhtar M, Nabi F, Ahmed N, Saleem M Biomed Res Int. 2023; 2023:2088988.
PMID: 36814796 PMC: 9940969. DOI: 10.1155/2023/2088988.
Heart Failure in Menopause: Treatment and New Approaches.
da Silva J, Montagnoli T, de Sa M, Zapata-Sudo G Int J Mol Sci. 2022; 23(23).
PMID: 36499467 PMC: 9735523. DOI: 10.3390/ijms232315140.